Enoxaparin 20mg Versus 30mg Subcutaneously Once Daily in Elderly Patients With Impaired Renal Function

NCT03158792 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

32

Enrollment

OTHER

Sponsor class

Conditions

Venous Thromboembolism
Renal Impairment

Interventions

DRUG: Enoxaparin 20Mg/0.2mL Prefilled Syringe
DRUG: Enoxaparin 60Mg/0.6Ml Inj Syringe 0.6Ml

Sponsor

Lebanese American University